Iron-binding proteins and 67Ga accumulation by tumor cells

Area of Science:

• Biochemistry
• Nuclear Medicine
• Oncology

Background:

• Gallium-67 (67Ga) citrate is a radiopharmaceutical used in diagnostic imaging.
• The uptake mechanisms of 67Ga by tumor cells are not fully understood.
• Iron-binding proteins like lactoferrin and transferrin may influence 67Ga uptake.

Purpose of the Study:

• To investigate the effect of lactoferrin and transferrin on 67Ga uptake by tumor cells.
• To explore the potential role of these proteins in 67Ga cellular accumulation.

Main Methods:

• Tumor cells were incubated with 67Ga-citrate in the presence of varying concentrations of lactoferrin or transferrin.
• The binding of 131I-labelled lactoferrin and transferrin to cells was measured.
• The effect of iron saturation on protein binding and 67Ga uptake was assessed.

Main Results:

• Lactoferrin increased 67Ga uptake in a concentration-dependent manner.
• Transferrin inhibited 67Ga uptake.
• A correlation was found between the binding of labeled lactoferrin/transferrin and 67Ga uptake.
• Preincubation with lactoferrin, transferrin, or ferric citrate enhanced 67Ga uptake.

Conclusions:

• Lactoferrin promotes 67Ga uptake by tumor cells, suggesting a potential role in 67Ga-based imaging or therapy.
• Transferrin appears to inhibit 67Ga uptake, possibly through competitive binding.
• The findings support the hypothesis of a ternary complex formation where 67Ga may mimic iron, influencing its cellular uptake by these proteins.